Penrhos Bio launches first product containing Remora technology
First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany
Today at the IDS dental trade fare in Cologne, Pro3dure Medical GmbH have launched a 3D printable polymer containing Remora® for use in the construction of dental reliners that helps control harmful biofilms.
The PrintoDent® GR-10 resin incorporated with RemoraR is being made available for use in 3D printed dental liners and dental blanks. The 3D printable dental market is estimated to be worth $3.2 billion in 2022 and is growing at 20.2% CAGR from 2022-2027.
Commenting, Dr Yvonne Davies, Head of Business Development for Penrhos Bio Ltd said ‘We announced our collaboration with Pro3dure Medical in 2022 and the team have done a great job incorporating RemoraR into their 3D printable resins. We look forward to commercial success across our divisions during 2023.’
Dr Martin Klare, CEO of Pro3dure Medical said ‘What Remora® offers us is a unique and patented approach to controlling harmful biofilms. Applying this in our Multi-Species Inhibition (MISR) product range allows us to offer our functional 3D printed dental materials.’
Remora® is inspired by the natural biology of the oceans and helps keep surfaces cleaner for longer. The technology has been developed over many years in Unilever and was recently licensed exclusively to Penrhos Bio Ltd for wider commercialisation beyond homecare applications.
